If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...

Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...

Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

A one-year-old baby boy has received an incredible honour, for helping researchers get one step closer to finding treatment ...

Genetic modification improves environmental credentials of ‘particularly promising’ substitute that outperforms poultry, ...

Chinese scientists have genetically tweaked a fungus to make protein-rich “meat”, which they say can be a low-cost, ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...

In the latest allocation of European funding for cutting-edge research, ETH Zurich scientists have performed exceptionally ...

DeepSeek's founder and CEO, Liang Wenfeng, has been listed among the top 10 "people who shaped science in 2025" by the ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...